Skip to Main Content

Amgen Inc

AMGN Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

$AMGN stock is featured in our Top Lobbying Spenders, Dan Meuser, and Sheldon Whitehouse strategies.

See All Strategies
Income
Balance Sheet
Cash Flow
AMGN Income Statement
AMGN Balance Sheet
AMGN Cash Flow

Recent trades of AMGN by members of U.S. Congress

Politician Type Traded
Sheldon Whitehouse Senate / D Sale (Partial) $1,001 - $15,000 Sep. 17, 2024
C. Scott Franklin House / R Purchase $50,001 - $100,000 Aug. 07, 2024
C. Scott Franklin House / R Purchase $1,001 - $15,000 Aug. 02, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 02, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jan. 23, 2024
Tommy Tuberville Senate / R Sale (Full) $15,001 - $50,000 Jan. 19, 2024
Michael C. Burgess House / R Sale $15,001 - $50,000 Jan. 02, 2024
HON. GREG STANTON House / D Sale $1,001 - $15,000 Oct. 24, 2023
HON. GREG STANTON House / D Purchase $1,001 - $15,000 Sep. 26, 2023
Jared Moskowitz House / D Purchase $1,001 - $15,000 Jul. 14, 2023
Shelley Moore Capito Senate / R Sale (Full) $1,001 - $15,000 Jun. 12, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 May. 01, 2023
Kathy E. Manning House / D Purchase $1,001 - $15,000 Apr. 28, 2023
Josh Gottheimer House / D Purchase $1,001 - $15,000 Apr. 12, 2023
Michael C. Burgess House / R Purchase $15,001 - $50,000 Apr. 05, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Mar. 27, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Mar. 06, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Feb. 22, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Jan. 27, 2023
Josh Gottheimer House / D Purchase $1,001 - $15,000 Dec. 09, 2022
Josh Gottheimer House / D Purchase $1,001 - $15,000 Oct. 19, 2022
Kathy E. Manning House / D Sale $1,001 - $15,000 Oct. 12, 2022
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Oct. 06, 2022
Earl Blumenauer House / D Purchase $1,001 - $15,000 Sep. 26, 2022
Rick W. Allen House / R Purchase $15,001 - $50,000 Aug. 18, 2022
Kathy E. Manning House / D Sale $1,001 - $15,000 Aug. 03, 2022
Kathy E. Manning House / D Sale $1,001 - $15,000 Jul. 27, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 27, 2022
Kathy E. Manning House / D Sale $1,001 - $15,000 Jul. 27, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 20, 2022
Josh Gottheimer House / D Purchase $1,001 - $15,000 May. 11, 2022
Earl Blumenauer House / D Sale $1,001 - $15,000 Mar. 14, 2022
Josh Gottheimer House / D Purchase $1,001 - $15,000 Mar. 03, 2022
Earl Blumenauer House / D Purchase $1,001 - $15,000 Feb. 24, 2022
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Feb. 22, 2022
John H. Rutherford House / R Sale $1,001 - $15,000 Feb. 17, 2022
Earl Blumenauer House / D Purchase $1,001 - $15,000 Feb. 11, 2022
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Jan. 12, 2022
Shelley Moore Capito Senate / R Purchase $1,001 - $15,000 Dec. 15, 2021
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Jul. 19, 2021
Kathy E. Manning House / D Purchase $1,001 - $15,000 Apr. 30, 2021
Carol D. Miller House / R Purchase $15,001 - $50,000 Mar. 04, 2021
Peter Meijer House / R Sale $1,001 - $15,000 Feb. 16, 2021
Kathy E. Manning House / D Sale $1,001 - $15,000 Jan. 15, 2021
Kathy E. Manning House / D Sale $1,001 - $15,000 Jan. 15, 2021
Bill Cassidy Senate / R Sale (Full) $1,001 - $15,000 Nov. 05, 2020
Josh Gottheimer House / D Sale $1,001 - $15,000 Oct. 22, 2020
Josh Gottheimer House / D Sale $1,001 - $15,000 Oct. 08, 2020
Carol D. Miller House / R Purchase $15,001 - $50,000 Jul. 28, 2020
John A. Yarmuth House / D Sale $1,001 - $15,000 May. 29, 2020
AMGN Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
AMGN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
AMGN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by AMGN's directors and management

Government lobbying spending instances

  • $15,000 Oct 21, 2024 Issue: Health Issues
  • $60,000 Oct 21, 2024 Issue: Health Issues
  • $2,770,000 Oct 21, 2024 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $60,000 Oct 21, 2024 Issue: Immigration Medicare/Medicaid Health Issues
  • $60,000 Oct 21, 2024 Issue: Pharmacy Medicare/Medicaid
  • $50,000 Oct 21, 2024 Issue: Medicare/Medicaid
  • $50,000 Oct 21, 2024 Issue: Health Issues
  • $80,000 Oct 20, 2024 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $50,000 Oct 19, 2024 Issue: Health Issues
  • $60,000 Oct 18, 2024 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $60,000 Oct 18, 2024 Issue: Law Enforcement/Crime/Criminal Justice Copyright/Patent/Trademark Labor Issues/Antitrust/Workplace Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $7,500 Oct 17, 2024 Issue: Health Issues
  • $60,000 Oct 15, 2024 Issue: Medicare/Medicaid
  • $30,000 Oct 14, 2024 Issue: Health Issues
  • $50,000 Oct 13, 2024 Issue: Medicare/Medicaid
  • $60,000 Jul 22, 2024 Issue: Immigration Medicare/Medicaid Health Issues
  • $2,740,000 Jul 22, 2024 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $60,000 Jul 22, 2024 Issue: Pharmacy Medicare/Medicaid
  • $60,000 Jul 22, 2024 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $50,000 Jul 22, 2024 Issue: Health Issues
  • $50,000 Jul 20, 2024 Issue: Health Issues
  • $50,000 Jul 19, 2024 Issue: Medicare/Medicaid
  • $5,000 Jul 19, 2024 Issue: Health Issues
  • $80,000 Jul 19, 2024 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $90,000 Jul 19, 2024 Issue: None
  • $7,500 Jul 15, 2024 Issue: Health Issues
  • $60,000 Jul 15, 2024 Issue: Medicare/Medicaid
  • $30,000 Jul 15, 2024 Issue: Health Issues
  • $60,000 Apr 22, 2024 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $60,000 Apr 22, 2024 Issue: Immigration Medicare/Medicaid Health Issues
  • $7,500 Apr 22, 2024 Issue: Health Issues
  • $60,000 Apr 22, 2024 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $50,000 Apr 22, 2024 Issue: Health Issues
  • $50,000 Apr 21, 2024 Issue: Medicare/Medicaid
  • $50,000 Apr 19, 2024 Issue: Health Issues
  • $90,000 Apr 19, 2024 Issue: None
  • $3,330,000 Apr 19, 2024 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $30,000 Apr 12, 2024 Issue: Health Issues
  • $60,000 Apr 12, 2024 Issue: Medicare/Medicaid
  • $60,000 Feb 07, 2024 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
  • $60,000 Jan 22, 2024 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $50,000 Jan 22, 2024 Issue: Medicare/Medicaid
  • $60,000 Jan 22, 2024 Issue: None
  • $50,000 Jan 22, 2024 Issue: Health Issues
  • $3,550,000 Jan 19, 2024 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $60,000 Oct 20, 2023 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $60,000 Oct 20, 2023 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $50,000 Oct 20, 2023 Issue: Health Issues
  • $2,240,000 Oct 19, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $50,000 Oct 19, 2023 Issue: Medicare/Medicaid
  • $50,000 Oct 19, 2023 Issue: Health Issues
  • $60,000 Oct 16, 2023 Issue: Health Issues Medicare/Medicaid
  • $2,140,000 Oct 16, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $1,950,000 Jul 21, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $50,000 Jul 20, 2023 Issue: Health Issues
  • $60,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $50,000 Jul 19, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
  • $50,000 Jul 19, 2023 Issue: Health Issues
  • $60,000 Jul 18, 2023 Issue: Trade (domestic/foreign) Budget/Appropriations Medicare/Medicaid Health Issues
  • $60,000 Jul 14, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Medicare/Medicaid
  • $60,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
  • $50,000 Jan 20, 2023 Issue: Health Issues
  • $80,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $50,000 Jan 19, 2023 Issue: Health Issues
  • $80,000 Jan 14, 2023 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
  • $80,000 Oct 20, 2022 Issue: Medicare/Medicaid
  • $60,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
  • $60,000 Oct 20, 2022 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
  • $50,000 Oct 20, 2022 Issue: Health Issues
  • $50,000 Oct 19, 2022 Issue: Health Issues
  • $3,150,000 Oct 18, 2022 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $80,000 Oct 16, 2022 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
  • $60,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
  • $2,200,000 Jul 20, 2022 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,410,000 Jul 20, 2022 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $50,000 Jul 20, 2022 Issue: Health Issues
  • $80,000 Jul 20, 2022 Issue: Medicare/Medicaid
  • $60,000 Jul 19, 2022 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
  • $50,000 Jul 19, 2022 Issue: Health Issues
  • $80,000 Jul 15, 2022 Issue: Communications/Broadcasting/Radio/TV Health Issues Medicare/Medicaid
  • $60,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
  • $60,000 Apr 20, 2022 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
  • $2,780,000 Apr 20, 2022 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $50,000 Apr 20, 2022 Issue: Health Issues
  • $80,000 Apr 20, 2022 Issue: Medicare/Medicaid
  • $50,000 Apr 19, 2022 Issue: Health Issues
  • $80,000 Apr 15, 2022 Issue: Health Issues Medicare/Medicaid
  • $70,000 Jan 21, 2022 Issue: Medicare/Medicaid Taxation/Internal Revenue Code
  • $2,410,000 Jan 20, 2022 Issue: None
  • $50,000 Jan 20, 2022 Issue: Health Issues
  • $80,000 Jan 19, 2022 Issue: Medicare/Medicaid
  • $50,000 Jan 19, 2022 Issue: Health Issues
  • $80,000 Jan 18, 2022 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $80,000 Jan 15, 2022 Issue: None
  • $70,000 Oct 20, 2021 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
  • $2,620,000 Oct 20, 2021 Issue: None
  • $80,000 Oct 20, 2021 Issue: Copyright/Patent/Trademark Medicare/Medicaid Health Issues
  • $50,000 Oct 20, 2021 Issue: Health Issues
  • $50,000 Oct 18, 2021 Issue: Health Issues
  • $80,000 Oct 18, 2021 Issue: None

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of AMGN in WallStreetBets Daily Discussion

AMGN News

Recent insights relating to AMGN

CNBC Recommendations

Recent picks made for AMGN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AMGN

AMGN Top Shareholders
Shareholder
Shares Held
AMGN Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

AMGN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view AMGN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top